3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1/2
4
Phase NA
1
Phase 4
1
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Sarcoma
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma
8
Liposarcoma
8
Hemangiosarcoma
8
Fibrosarcoma
8
Lymphoma, Large B-Cell, Diffuse
7
Sarcoma, Synovial
6
Rhabdomyosarcoma
6
Neurofibrosarcoma
6
Malignant mesenchymal tumor
6
Leukemia
6
Leiomyosarcoma
6
Histiocytoma, Malignant Fibrous
6
Hemangiopericytoma, Malignant
6
Testicular Neoplasms
5
Teratoma
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Lung Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Testicular Germ Cell Tumor
4
Ovarian Neoplasms
4
Lymphoma, Non-Hodgkin
4
Endodermal Sinus Tumor
4
Seminoma
3
Neuroblastoma
3
Neoplasm Metastasis
3
Lymphoma, Follicular
3
Hodgkin Disease
3
Carcinoma, Embryonal
3
Interventions
Doxorubicin
8
Vincristine
7
Prednisone
7
Cyclophosphamide
7
Rituximab
5
VAP-cyclo protocol
3
Radiotherapy
3
Methotrexate
3
Filgrastim
3
Cytarabine
3
liposomal amphotericin B
2
Vinblastine
2
Levofloxacin
2
Leucovorin
2
Hydrocortisone
2
Etoposide
2
Early Intervention, Educational
2
Drug Therapy
2
Dexamethasone
2
Darbepoetin alfa
2
liposomal doxorubicin
1
ferrous sulfate
1
ferric gluconate
1
belinostat
1
Sucrose
1
Steroids
1
Stem Cell Transplantation
1
Standard of Care
1
Specimen Handling
1
Psychiatric Rehabilitation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, Large-Cell, Anaplastic
×
Ifosfamide
×
Clear all
NCT00006455
2022-05-31
ALCL 99
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
Completed
885 enrolled